Safety and Performance of Continuous Glucose Monitoring: An Overview.
CGM
Hypoglycemia
artificial pancreas
diabetes
glucose
glycemic control
Journal
Current diabetes reviews
ISSN: 1875-6417
Titre abrégé: Curr Diabetes Rev
Pays: United Arab Emirates
ID NLM: 101253260
Informations de publication
Date de publication:
2023
2023
Historique:
received:
04
10
2021
revised:
06
01
2022
accepted:
03
03
2022
pubmed:
28
5
2022
medline:
28
3
2023
entrez:
27
5
2022
Statut:
ppublish
Résumé
Diabetes (Type 1 and Type 2) is the most burdensome condition for the healthcare systems worldwide. Continuous glucose monitoring (CGM) is a powerful tool in the management of diabetes that has helped patients with diabetes to achieve better glycemic control as compared to traditional systems. It helps reduce the frequency as well as the severity of hypoglycemia. Continuous glucose monitoring technology is an integral part of the 'artificial pancreas'. This review provides an overview of CGM technology and its applications.
Identifiants
pubmed: 35619270
pii: CDR-EPUB-123954
doi: 10.2174/1573399818666220525111746
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e250522205241Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.